Qube Research & Technologies (QRT)
OBIO icon

Qube Research & Technologies (QRT)’s Orchestra BioMed OBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$463K Buy
108,953
+2,211
+2% +$9.41K ﹤0.01% 2762
2025
Q4 		$443K Buy
106,742
+80,808
+312% +$326K ﹤0.01% 2837
2025
Q3 		$64.3K Buy
+25,934
New +$71.5K ﹤0.01% 3141

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OBIO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Orchestra BioMed (OBIO) stake by 2.1% in Q1 2026, buying an estimated $9.41K and bringing the position to 108,953 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Qube Research & Technologies (QRT) first reported a position in OBIO in Q3 2025 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold OBIO as of Q1 2026.

  • Qube Research & Technologies (QRT) held 108,953 shares of Orchestra BioMed worth $463K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 2,211 Orchestra BioMed shares in Q1 2026, an estimated $9.41K.
  • Orchestra BioMed made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2762 holding.
  • Qube Research & Technologies (QRT) first reported a position in Orchestra BioMed in Q3 2025 and has held it in 3 quarters since.
  • 65 funds tracked by Wall St. Rank held Orchestra BioMed as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.